Inhibition of Differentiation by Transforming Growth Factor ß1 in Rhabdomyosarcoma Cells

REFERENCES

1. ↵
   1. Massague J,
   2. Chen YG.

   Controlling TGF-β signaling. Genes Dev 2000; 14: 627-644.

   OpenUrlFREE Full Text
2. ↵
   1. Levy L,
   2. Hill CS.

   Alterations in components of the TGF-ß superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006; 17: 41-58.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Sporn MB,
   2. Roberts AB.

   TGF-β: Problems and prospects. Cell Regul 1990; 1: 875-882.

   OpenUrlPubMedWeb of Science
4. ↵
   1. Liu D,
   2. Black BL,
   3. Derynck R.

   TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes 2001; 22: 2950-2966.

   OpenUrl
5. ↵
   1. Olson EN.

   Interplay between proliferation and differentiation within the myogenic lineage. Development Biology 1992; 154: 261-272.

   OpenUrl
6. ↵
   1. Dias P,
   2. Pharham DM,
   3. Shapiro DN, et al.

   Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: Diagnostic utility in rhabdomyosarcoma. Am J Pathol 1991; 137:1283-1291.

   OpenUrl
7. ↵
   1. Parham DM.

   The molecular biology of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994; 11: 39-46.

   OpenUrlPubMed
8. ↵
   1. Wang H,
   2. Yang GH,
   3. Bu H, et al.

   Systematic analysis of the TGF-β/Smad signaling pathway in the rhabdomyosarcoma cell line RD. Int J Exp Path 2003; 84:153-163.

   OpenUrlPubMed
9. ↵
   1. Ye L,
   2. Zhang HY,
   3. Wang H, et al.

   Effects of transforming growth factor beta1 on the growth of rhabdomyosarcoma cell line RD. Chin Med J 2005; 118: 678-686.

   OpenUrl
10. ↵
    1. McAllister RM,
    2. Melnyk J,
    3. Finkelstein JZ, et al.

    Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 1969; 24: 520-526.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Jason WB,
    2. Joe CW,
    3. Marieke M, et al.

    Differentiation of rhabdomyosarcoma cell lines using retinoic acid. Pediatr Blood Cancer 2006; 47: 733-784.

    OpenUrl
12. ↵
    1. Stevens MCG.

    Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 2005; 6: 77-84.

    OpenUrlCrossRefPubMed
13. ↵
    1. Xu Q,
    2. Wu Z.

    The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem 2000; 275: 36750-36757.

    OpenUrlAbstract/FREE Full Text
14. ↵
    1. Ricaud S,
    2. Vernus B,
    3. Duclos M, et al.

    Inhibition of autocrine secretion of myostatin enhances terminal differentiation in human rhabdomyosarcoma cells. Oncogene 2003; 22: 8221-8232.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Okuno M,
    2. Kojima S,
    3. Matsushima-Nishiwaki R, et al.

    Retinoids in Cancer Chemoprevention Current Cancer Drug Targets 2004; 4: 285-298.

    OpenUrl
16. ↵
    1. Hamade A,
    2. Deries M,
    3. Begemann G, et al.

    Retinoic acid activates myogenesis in vivo through Fgf8 signalling. Dev Biol 2006; 289:127-140.

    OpenUrlCrossRefPubMed
17. ↵
    1. Ricaud S,
    2. Vernus B,
    3. Bonnieu A, et al.

    Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity. Exp Cell Res 2005; 311:192-204.

    OpenUrlPubMed
18. ↵
    1. Sebire NJ,
    2. Malone M.

    Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 2003;56:412-416.

    OpenUrlAbstract/FREE Full Text
19. ↵
    1. Kumar S,
    2. Perlman E,
    3. Harris CA et al.

    Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissue. Mod Pathol 2000;13:988-993.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    1. Myer A,
    2. Olson EN,
    3. Klein WH.

    MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells. Dev Biol 2001; 229:340-350.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Guo H,
    2. Zhang HY,
    3. Wang SL, et al.

    Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma. Chin Med J 2007; 120: 515-521.

    OpenUrl